Anhui Saidi Biotechnology Co., Ltd.

On Chemball

My Chemball

As Supplier

My RFQ Manage Products

As Buyer

My RFQ Post RFQ

My Account

+86-571-8627 3270

Anhui SaidI Biotechnology Co., Ltd.

11 YRS

Anhui, China

CNY 36 Million

49950 m²

50-100 people

Main Products: Tetraethylammonium Bromide / 1-Chlorobutane / 1-(4-Chlorophenyl)-4,4-Dimethyl-3-Pentanone / 4-Bromo-N,N-Dimethylaniline / Benzoyl Chloride / Benzyltrimethylammonium Chloride / Benzyltriethylammonium Bromide / Benzyltriethylammonium Chloride / Benzyltrimethylammonium Bromide / Trometamol / Tetrapropylammonium Bromide / Tetrabutylammonium Fluoride / Tetrabutylammonium Hydrogen Sulfate / Tetrabutylammonium Tetrafluoroborate / Tetramethyl Ammonium Chloride / Tetramethylammonium Bromide / Tetraoctylammonium Bromide / Tetraethylammonium Chloride / Tetrabutylammonium Bromide

Anhui, China

Contact Supplier

Home Company Profile Contact Us Post Buying Request

ABOUT US

Anhui SaidI Biotechnology Co., Ltd., founded in 2013 and located in Dingyuan Salt Chemical Industrial Park, Anhui Province, is mainly engaged in the production and sales of fine chemicals, pharmaceuticals, pesticide intermediates and disinfectants. The company has a modern R&D center, strong ability of new product development and technology transformation, complete public facilities, advanced equipment, rigorous internal management, excellent product quality and clean plant environment. The company covers an area of 75 mu, with one hydrogenation workshop, one chlorination workshop, one fine chemical workshop, perfect sewage treatment devices and environmental protection facilities. The main products of Anhui saidI Biotechnology Co., Ltd. are pharmaceutical intermediate p-chlorobenzoyl chloride 4000t, with an output value of 120 million yuan, p-chlorobenzyl chloride 2000t, with an output value of 40 million yuan, hydrogenation products 2000t, with an output value of 100 million yuan, disinfectant series products about 40 million yuan, annual sales: 300 million yuan and tax revenue of 20-30 million yuan. In addition to bulk products, the company is committed to the development of pharmaceutical products with the highest added value. It mainly includes pyridine series products, such as 2-amino-5-bromopyridine, 2,5-dibromopyridine, etc; Pyrazole series, such as: 3-methyl pyrazole, 3-methyl-4-nitropyrazole, 4-pyrazole ethyl formate, etc; Pyrimidine series such as 2-hydroxy-5-iodopyrimidine and fluorine-containing compounds such as 2-hydroxy-5-trifluoromethylpyridine. At present, the company has more than 60 employees, of which more than 40% are scientific and technological personnel at college level or above. It also has several high-tech talents such as doctors and masters in drug research and development and organic synthesis, and has three independent patent applications. Adhering to the concept of "focusing on science and technology, focusing on quality and efficiency", seidi is committed to building a good and efficient management team for the society, and is committed to the spirit of "unity and dedication to science and technology"!

Basic Information